DK2075004T3 - Anvendelse af epidermal vækstfaktor til morphofunktionel genoprettelse af perifere nerver ved diabetisk neuropati - Google Patents

Anvendelse af epidermal vækstfaktor til morphofunktionel genoprettelse af perifere nerver ved diabetisk neuropati

Info

Publication number: DK2075004T3
Authority: DK; Denmark
Prior art keywords: morphofunctional; growth factor; epidermal growth; peripheral nerve; diabetic neuropathy
Prior art date: 2006-10-03

Application number

DK07817382.0T

Other languages

English (en)

Inventor

Martinez Luis Saturnino Herrera

Del Barco Herrera Diana Garcia

Vera Danay Cibrian

Montequin Jose Ignacio Fernandez

Acosta Jorge Amador Berlanga

Nieto Gerardo Enrique Guillen

Gomez Raimundo Ubieta

Blanco Sonia Gonzalez

Martinez Vivian Maria Saez

Original Assignee

Ct Ingenieria Genetica Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-03

Filing date

2007-10-01

Publication date

2012-05-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38925545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2075004(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-01 Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech

2012-05-14 Application granted granted Critical

2012-05-14 Publication of DK2075004T3 publication Critical patent/DK2075004T3/da

Links

208000032131 Diabetic Neuropathies Diseases 0.000 title 1
102000009024 Epidermal Growth Factor Human genes 0.000 title 1
101800003838 Epidermal growth factor Proteins 0.000 title 1
229940116977 epidermal growth factor Drugs 0.000 title 1
210000000578 peripheral nerve Anatomy 0.000 title 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK07817382.0T 2006-10-03 2007-10-01 Anvendelse af epidermal vækstfaktor til morphofunktionel genoprettelse af perifere nerver ved diabetisk neuropati DK2075004T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CU20060192A CU23526B6 (es)	2006-10-03	2006-10-03	Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
PCT/CU2007/000018 WO2008040260A1 (es)	2006-10-03	2007-10-01	Uso del factor de crecimiento epidérmico para la restauración morfofuncional de nervios periféricos en la neuropatía diabética

Publications (1)

Publication Number	Publication Date
DK2075004T3 true DK2075004T3 (da)	2012-05-14

Family

ID=38925545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07817382.0T DK2075004T3 (da)	2006-10-03	2007-10-01	Anvendelse af epidermal vækstfaktor til morphofunktionel genoprettelse af perifere nerver ved diabetisk neuropati

Country Status (20)

Country	Link
US (2)	US8642552B2 (da)
EP (1)	EP2075004B1 (da)
JP (1)	JP5508853B2 (da)
KR (1)	KR101464208B1 (da)
CN (1)	CN101573130B (da)
AR (1)	AR063088A1 (da)
AT (1)	ATE544462T1 (da)
AU (1)	AU2007304640B2 (da)
BR (1)	BRPI0719816B8 (da)
CA (1)	CA2665117C (da)
CL (1)	CL2007002862A1 (da)
CU (1)	CU23526B6 (da)
DK (1)	DK2075004T3 (da)
ES (1)	ES2386058T3 (da)
MX (1)	MX2009003678A (da)
PL (1)	PL2075004T3 (da)
PT (1)	PT2075004E (da)
RU (1)	RU2460536C2 (da)
WO (1)	WO2008040260A1 (da)
ZA (1)	ZA200902311B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101252740B1 (ko) *	2011-05-25	2013-04-11	연세대학교 산학협력단	센서 및 센싱방법
EP2737895A1 (en) *	2012-11-30	2014-06-04	Praxis Pharmaceutical, S.A.	Microparticles with EGF, method of preparation and use
KR102228358B1 (ko) *	2012-12-21	2021-03-16	쉬케후세트 솔란데트 에이치에프	신경 장애 및 통증의 ｅｇｆｒ 표적 치료
CA2920835A1 (en)	2013-08-20	2015-02-26	Anutra Medical, Inc.	Syringe fill system and method
IL312865B2 (en) *	2013-09-11	2025-06-01	Eagle Biologics Inc	Liquid protein formulations containing viscosity-lowering agents
USD774182S1 (en)	2014-06-06	2016-12-13	Anutra Medical, Inc.	Anesthetic delivery device
USD750768S1 (en)	2014-06-06	2016-03-01	Anutra Medical, Inc.	Fluid administration syringe
USD763433S1 (en)	2014-06-06	2016-08-09	Anutra Medical, Inc.	Delivery system cassette
SG11201702614SA (en)	2014-10-01	2017-04-27	Eagle Biolog Inc	Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
RU2585421C1 (ru) *	2014-12-24	2016-05-27	Артур Владимирович Маргасов	Способ восстановления поврежденного нерва

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5130298A (en) *	1989-05-16	1992-07-14	Ethicon, Inc.	Stabilized compositions containing epidermal growth factor
SE9601243D0 (sv) *	1996-03-29	1996-03-29	Hans Arne Hansson	Promotion of regeneration of organized tissues
AU2231399A (en)	1998-01-20	1999-08-02	Aurx, Inc.	A herpes virus vector
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
SE9804064D0 (sv)	1998-11-25	1998-11-25	A & Science Invest Ab	Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
CA2365434A1 (en) *	1999-04-15	2000-10-26	St. Elizabeth's Medical Center Of Boston	Angiogenic growth factors for treatment of peripheral neuropathy
AU2001281254A1 (en)	2000-08-10	2002-02-18	Pharmacia Corporation	A new egf motif repeat protein obtained from a cdna library from hs-5 stromal cell line
CU23157A1 (es)	2001-01-03	2006-07-18	Ct Ingenieria Genetica Biotech	COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
JP2006152001A (ja)	2001-03-12	2006-06-15	Institute Of Gene & Brain Science	神経損傷の治療薬
JP3607271B2 (ja)	2001-03-12	2005-01-05	株式会社Ｇｂｓ研究所	神経損傷の治療薬
CU23043A1 (es) *	2001-12-20	2005-05-20	Ct Ingenieria Genetica Biotech	Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
US7465463B2 (en)	2002-09-04	2008-12-16	Polyheal, Ltd.	Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2004084819A2 (en) *	2003-03-19	2004-10-07	University Of Kentucky Research Foundation	Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
ATE482713T1 (de) *	2003-04-25	2010-10-15	Univ Pittsburgh	Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und - regeneration
WO2006012707A1 (en)	2004-08-06	2006-02-09	Gropep Limited	Method for treating diabetes
MX2007008826A (es)	2005-01-21	2007-11-15	Univ Northwestern	Metodos y composiciones para encapsulacion de celulas.
KR100765496B1 (ko)	2005-12-09	2007-10-10	경희대학교 산학협력단	히레귤린 베타1의 ｅｇｆ-성 도메인 펩타이드를 암호화하는ｄｎａ 서열을 포함하는 재조합 아데노바이러스 및 이를포함하는 신경세포 분화 및 재생용 약학 조성물

2006
- 2006-10-03 CU CU20060192A patent/CU23526B6/es active IP Right Grant
2007
- 2007-10-01 JP JP2009530751A patent/JP5508853B2/ja active Active
- 2007-10-01 RU RU2009116646/15A patent/RU2460536C2/ru active
- 2007-10-01 PL PL07817382T patent/PL2075004T3/pl unknown
- 2007-10-01 PT PT07817382T patent/PT2075004E/pt unknown
- 2007-10-01 US US12/443,837 patent/US8642552B2/en not_active Expired - Fee Related
- 2007-10-01 MX MX2009003678A patent/MX2009003678A/es active IP Right Grant
- 2007-10-01 DK DK07817382.0T patent/DK2075004T3/da active
- 2007-10-01 CN CN2007800422158A patent/CN101573130B/zh not_active Expired - Fee Related
- 2007-10-01 AT AT07817382T patent/ATE544462T1/de active
- 2007-10-01 EP EP07817382A patent/EP2075004B1/en not_active Not-in-force
- 2007-10-01 AR ARP070104350A patent/AR063088A1/es unknown
- 2007-10-01 BR BRPI0719816A patent/BRPI0719816B8/pt not_active IP Right Cessation
- 2007-10-01 CA CA2665117A patent/CA2665117C/en not_active Expired - Fee Related
- 2007-10-01 AU AU2007304640A patent/AU2007304640B2/en not_active Ceased
- 2007-10-01 KR KR1020097009188A patent/KR101464208B1/ko not_active Expired - Fee Related
- 2007-10-01 ES ES07817382T patent/ES2386058T3/es active Active
- 2007-10-01 WO PCT/CU2007/000018 patent/WO2008040260A1/es not_active Ceased
- 2007-10-03 CL CL200702862A patent/CL2007002862A1/es unknown
2009
- 2009-04-02 ZA ZA200902311A patent/ZA200902311B/xx unknown
2013
- 2013-12-26 US US14/140,849 patent/US9034826B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20140105990A1 (en)	2014-04-17
WO2008040260A1 (es)	2008-04-10
CN101573130B (zh)	2012-10-31
JP5508853B2 (ja)	2014-06-04
KR101464208B1 (ko)	2014-12-04
EP2075004B1 (en)	2012-02-08
BRPI0719816B1 (pt)	2018-04-24
ZA200902311B (en)	2010-04-28
AU2007304640A1 (en)	2008-04-10
PL2075004T3 (pl)	2012-09-28
RU2460536C2 (ru)	2012-09-10
KR20090103862A (ko)	2009-10-01
MX2009003678A (es)	2009-04-22
CA2665117A1 (en)	2008-04-10
PT2075004E (pt)	2012-05-02
US8642552B2 (en)	2014-02-04
CU23526B6 (es)	2010-05-19
CN101573130A (zh)	2009-11-04
CL2007002862A1 (es)	2008-05-23
US20100136062A1 (en)	2010-06-03
RU2009116646A (ru)	2010-11-10
ES2386058T3 (es)	2012-08-08
BRPI0719816A2 (pt)	2015-09-08
BRPI0719816B8 (pt)	2021-05-25
EP2075004A1 (en)	2009-07-01
AR063088A1 (es)	2008-12-23
AU2007304640B2 (en)	2013-01-17
US9034826B2 (en)	2015-05-19
JP2010505773A (ja)	2010-02-25
ATE544462T1 (de)	2012-02-15
CA2665117C (en)	2015-04-14

Publication	Publication Date	Title
EP2297182A4 (en)	2012-08-15	HIGHLY CHARGED PROTEINS USED FOR CELL PENETRATION
BRPI0913739A2 (pt)	2015-08-18	Composição líquida, método, e, uso de composição
DK2340031T3 (da)	2019-07-15	Gdf-fanger til anvendelse ved behandling af anæmi
BRPI0920263A2 (pt)	2016-07-12	composto, uso do composto, composição, e, método
EP2060040A4 (en)	2011-09-07	USE OF PHRASE TOKENS IN TRANSACTIONS
EP2018416A4 (en)	2012-04-25	DISPOSABLE BIOREACTOR
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0907424A2 (pt)	2015-07-14	Substrato de monólito de filtro, método de preparar o substrato de monólito de filtro, e, uso do monólito de filtro
BRPI0918586A2 (pt)	2015-12-01	compostos, composições e métodos de uso dos mesmos para a modulação dos níveis de ácido úrico
BRPI0906186A2 (pt)	2015-09-22	composto e uso de um composto
BRPI0920145A2 (pt)	2017-06-06	compostos de tioamida, método de produção e método de uso dos mesmos
ATE544462T1 (de)	2012-02-15	Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie
DK2379465T3 (da)	2013-04-08	Væv til maling indeholdende et middel egnet til opsamling af formaldehyd og fremgangsmåde til fremstilling
DK1905443T3 (da)	2011-03-28	Væske omfattende trehalose til anvendelse ved forhindring af vævsadhæsion
BRPI0915134A2 (pt)	2016-02-16	composto, e, uso de um composto
DK2257272T3 (da)	2014-01-20	Fremgangsmåde til kosmetisk behandling af fotoaldring i hud
EP2318026A4 (en)	2012-09-12	COMPOSITION FOR CONTROLLING AN INCREASE IN GLYCEMIA
BRPI1015363A2 (pt)	2015-08-25	Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit
BRPI0919216A2 (pt)	2015-12-08	poliuretano, e, uso de um poliuretano
ATE535599T1 (de)	2011-12-15	Erdbeckenfermenter
BRPI0909885A2 (pt)	2015-10-27	composição decorativa e método para sua utilização
BRPI0915473A2 (pt)	2015-11-10	composto, composição farmacêutica, e, uso de um composto
EP2091530A4 (en)	2010-08-04	Composition for inhibiting nadph oxidase activity
BRPI0907053A2 (pt)	2015-07-07	Poliisobutenoamina, composição combustível, e, uso de poliisobutenoaminas
DK2441462T3 (da)	2019-06-24	Fremgangsmåde til behandling af type I-diabetes